Healthcare

Medical Developments International Limited (ASX:MVP) attracted investor attention after its shares climbed26.28%toAUD 0.493, giving the healthcare company a market capitalisation of approximatelyAUD 55.48 million. While the stock remained lower over the past year, the latest rally coincided with growing market focus on the company's …

• PolyNovo shares dropped 8.65% to $0.85, far outpacing the 0.90% fall in the ASX Health Care index.

• Paragon Care rose 3.85% to 14 cents on 24 July 2026, outperforming a Health Care index down 0.90% and an ASX 200 off 0.40%.

• No single verified same-day catalyst was identified; the move reads as an idiosyncratic biotech advance.

Telix Pharmaceuticals (ASX:TLX) has pulled off one of the most eye-catching partnerships in Australian biotech history, unveiling a strategic radiopharmaceutical collaboration with US drug-development powerhouse Regeneron to build a new generation of cancer therapies. The tie-up pairs Telix's fast-growing radiopharmaceutical business with one of …

TrivarX Limited (ASX:TRI) has cleared one of the less glamorous but genuinely decisive hurdles standing between a laboratory concept and a first-in-human study: making sure it actually has the material to put into patients. The Perth-based health technology company says it has secured critical …

Vitrafy Life Sciences (ASX:VFY) has taken a significant step into the United States healthcare market, unveiling a collaboration with Vitalant, one of the country's largest non-profit blood and biotherapies networks. The agreement puts the Melbourne-based cryopreservation company's technology directly inside the operations of an …